116 related articles for article (PubMed ID: 1438448)
1. Alkyl-lysophospholipid purging for autologous bone marrow transplantation in acute leukemia in second or subsequent remission after extramedullary relapse.
Berdel WE; Vogler WR; Olson AC
Prog Clin Biol Res; 1992; 377():79-85. PubMed ID: 1438448
[No Abstract] [Full Text] [Related]
2. Efficacy of purging clonogenic leukemia cells using ether lipid and hyperthermia for autologous bone marrow transplantation.
Min WS; Park HM; Han CH; Park JW; Kim CC; Kim DJ
Prog Clin Biol Res; 1992; 377():87-95. PubMed ID: 1438449
[No Abstract] [Full Text] [Related]
3. Autologous bone marrow transplantation in acute leukemia with marrow purged with alkyl-lysophospholipid.
Vogler WR; Berdel WE; Olson AC; Winton EF; Heffner LT; Gordon DS
Blood; 1992 Sep; 80(6):1423-9. PubMed ID: 1520869
[TBL] [Abstract][Full Text] [Related]
4. [Role of marrow purging].
Rizzoli V; Carlo-Stella C; Mangoni L
Haematologica; 1991 Jun; 76 Suppl 3():311-20. PubMed ID: 1684346
[No Abstract] [Full Text] [Related]
5. The cytotoxicity of alkyl-lysophospholipid on clonogenic leukemia cells and on normal bone marrow progenitor cells is highly, but differentially, increased by cryopreservation.
Verdonck LF; Heesbeen EC; van Heugten HG; Staal GE; Rijksen G
Bone Marrow Transplant; 1992 Apr; 9(4):241-5. PubMed ID: 1600412
[TBL] [Abstract][Full Text] [Related]
6. Purging leukemia remission marrows with alkyl-lysophospholipids, preclinical and clinical results.
Vogler WR; Olson AC; Berdel WE; Okamoto S; Glasser L
Prog Clin Biol Res; 1990; 333():1-18; discussion 19-20. PubMed ID: 2308973
[TBL] [Abstract][Full Text] [Related]
7. Autologous bone marrow transplantation with in vitro chemotherapy purge in first remission of acute myeloid leukemia.
Stadtmauer EA; Edelstein M; Lin E; Spitalnik S; Silberstein L; Cassileth PA
Prog Clin Biol Res; 1992; 377():273-9. PubMed ID: 1438425
[No Abstract] [Full Text] [Related]
8. Autologous bone marrow rescue for patients with acute myelogenous leukemia: purging with hyperthermia and ether lipid in vitro.
Min W; Kim D; Lee J; Park J; Kim C; Kim D
Prog Clin Biol Res; 1994; 389():197-203. PubMed ID: 7700903
[No Abstract] [Full Text] [Related]
9. Autologous bone marrow transplantation for leukemia.
Stuart RK
Semin Oncol; 1993 Oct; 20(5 Suppl 6):40-54. PubMed ID: 8211215
[TBL] [Abstract][Full Text] [Related]
10. Autologous bone marrow transplantation with alkyl-lysophospholipid-purged marrow.
Vogler WR; Berdel WE
J Hematother; 1993; 2(1):93-102. PubMed ID: 7921970
[TBL] [Abstract][Full Text] [Related]
11. Autologous bone marrow transplantation for acute myeloid leukemia using monoclonal antibody-purged bone marrow.
Ball ED; Mills L; Hurd D; McMillan R; Gingrich R
Prog Clin Biol Res; 1992; 377():97-110; discussion 111. PubMed ID: 1438450
[No Abstract] [Full Text] [Related]
12. In vitro effects of Ilmofosine on acute lymphoblastic leukemia cells and on normal hemopoietic cells.
Skala JP; Rogers PC; Chan KW; Khangura SS; Rodriguez WC
Prog Clin Biol Res; 1992; 377():63-9. PubMed ID: 1438445
[No Abstract] [Full Text] [Related]
13. [Purging of leukemic cells using alkyllysophospholipid].
Okamoto S; Shoji M
Rinsho Ketsueki; 1992 Jul; 33(7):908-12. PubMed ID: 1507412
[No Abstract] [Full Text] [Related]
14. Purging in BCR-ABL-positive acute lymphoblastic leukemia using immunomagnetic beads: comparison of residual leukemia and purging efficiency in bone marrow vs peripheral blood stem cells by semiquantitative polymerase chain reaction.
Atta J; Fauth F; Keyser M; Petershofen E; Weber C; Lippok G; Hoelzer D; Martin H
Bone Marrow Transplant; 2000 Jan; 25(1):97-104. PubMed ID: 10654022
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow purging in patients with refractory cancer.
Meagher RC; Stevens DA; Herzig GP; Fay JW; Harden EA; Montes VM; Heye MM; Herzig RH
Prog Clin Biol Res; 1992; 377():281-7. PubMed ID: 1438426
[No Abstract] [Full Text] [Related]
16. Bone marrow purging with etoposide/methylprednisolone in patients undergoing autologous bone marrow transplantation.
Pineiro L; Fay J; Collins R; Herzig G
Prog Clin Biol Res; 1994; 389():17-21. PubMed ID: 7700899
[No Abstract] [Full Text] [Related]
17. Busulfan plus etoposide as a preparative regimen for autologous bone marrow transplantation for acute myelogenous leukemia: an update.
Linker CA; Damon LE; Ries CA; Rugo HS; Wolf JL
Semin Oncol; 1993 Aug; 20(4 Suppl 4):40-8; quiz 49. PubMed ID: 8342075
[TBL] [Abstract][Full Text] [Related]
18. Autologous bone marrow transplantation after in vitro purging with monoclonal antibodies and complement in acute lymphoblastic leukemia.
Perez-Oteyza J; Larana JG; Brieva J; Roldan E; Odriozola J; Maldonado M; Otheo E; Munoz A; Bootello A; Navarro JL
Prog Clin Biol Res; 1992; 377():163-8. PubMed ID: 1438412
[No Abstract] [Full Text] [Related]
19. Autologous transplantation of chemotherapy-purged PBSC collections from high-risk leukemia patients: a pilot study.
Lemoli RM; Visani G; Leopardi G; Motta MR; Rizzi S; Testoni N; Curti A; Tura S
Bone Marrow Transplant; 1999 Feb; 23(3):235-41. PubMed ID: 10084254
[TBL] [Abstract][Full Text] [Related]
20. Autologous BMT in high risk patients with CALLA-positive ALL: possible efficacy of ex vivo marrow leukemia cell purging with monoclonal antibodies and complement.
Morishima Y; Miyamura K; Kojima S; Ueda R; Morishita Y; Sao H; Tanimoto M; Ohno R; Sobue R; Hirano M
Bone Marrow Transplant; 1993 Apr; 11(4):255-9. PubMed ID: 7683550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
